Skip to content
Sign in
Business opportunities for Amass Biosystems

Compatibility /100

41/100

Medium potential

Why talk

  1. Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.
  2. ZymoChem (Series A) is well ahead of Amass Biosystems (Pre-seed): mentoring and investor intros.
  3. Amass Biosystems likely needs funding for the next round — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers5.0Market bridge3.5Customer potential0.0Sector synergy25.0Stage complementarity7.5

Dimension by dimension

Needs ↔ offers

5.0 / 10 pts

ZymoChem can help Amass Biosystems.

  • Amass Biosystems likely needs funding for the next round — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).

Market bridge

3.5 / 10 pts

Distant markets.

  • Both are based in United States: shared local customers, investors and ecosystem.

Customer potential

0.0 / 5 pts

Neither side has a product on the market yet.

No supporting signal in the records.

Sector synergy

25.0 / 50 pts

Complementary sectors.

  • Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.

Stage complementarity

7.5 / 25 pts

Weak stage signal.

  • ZymoChem (Series A) is well ahead of Amass Biosystems (Pre-seed): mentoring and investor intros.

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Peers”: Needs ↔ offers 10, Market bridge 10, Customer potential 5, Sector synergy 50, Stage complementarity 25. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 42/100 — high from 50, medium from 36.